LON:ALK Alkemy Capital Investments Interim Earnings Results & Report GBX 270 0.00 (0.00%) As of 03:19 AM Eastern Alkemy Capital Investments reported Interim earnings on October 15, 2025. The company reported EPS of -GBX 11.90. Research:ProfileEarnings History Earnings Announcement Details QuarterInterimReport DateOctober 15, 2025TimeBefore Market Opens Alkemy Capital Investments EPS ResultsActual EPS-GBX 11.90Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AAlkemy Capital Investments Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesEarnings HistoryCompany Profile Alkemy Capital Investments Interim Earnings FAQ Did Alkemy Capital Investments beat earnings estimates for Interim? Alkemy Capital Investments (LON:ALK) reported earnings of -GBX 11.90 per share for Interim. The report was announced on Wednesday, October 15, 2025. Alkemy Capital Investments Earnings HeadlinesAlkemy Capital Investments (LON:ALK) Shares Cross Below Two Hundred Day Moving Average - Here's What HappenedOctober 3, 2026 | americanbankingnews.comGlencore visit bolsters Tees Valley Lithium refinery partnershipSeptember 29, 2026 | tipranks.comThe Executive Order That Quietly Changed What Your Dollar MeansOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free. | Reagan Gold Group (Ad)Alkemy Capital Receives £18.3 Million UK Government Grant Offer for Tees Valley Lithium RefinerySeptember 17, 2026 | uk.finance.yahoo.comWINNERS & LOSERS: Alkemy Capital gets grant; OptiBiotix loss widensSeptember 17, 2026 | lse.co.ukUK Backs Alkemy’s Tees Valley Lithium Refinery with £18.3m Grant OfferSeptember 17, 2026 | tipranks.comSee More Alkemy Capital Investments Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Alkemy Capital Investments? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Alkemy Capital Investments and other key companies, straight to your email. Email Address About Alkemy Capital InvestmentsAlkemy Capital Investments (LON:ALK) develops projects in the energy transition metals sector in the United Kingdom and Australia. It engages in the construction and operation of the lithium hydroxide processing facility and the lithium ore enrichment facility. The company also focuses on designing, developing, constructing, and operating of the plant that produces lithium hydroxide monohydrate. The company was formerly known as Alkemy Capital Plc and changed its name to Alkemy Capital Investments Plc in February 2021. Alkemy Capital Investments Plc was incorporated in 2021 and is based in London, the United Kingdom.View Alkemy Capital Investments ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Levi's Stock Dip Reveals Value Opportunity Despite Q3 HeadwindsPepsiCo Stock Looks Poised to Bottom With High Yield, Deep ValueSkydance Just Became a Media Giant—With an $80 Billion Debt LoadConstellation Brands Beat Earnings, But Beer Demand Is Still a ProblemTesla's EV Delivery Beat Is In, So What Happens Now?BigBear.ai Is Heavily Shorted—and Its Fundamentals Are Starting to ChangePenguin Solutions Is Soaring as AI Memory Demand Explodes Upcoming Earnings Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
